Article Details
Retrieved on: 2020-12-15 14:03:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... trials for CM-101 in fibrotic indications, focusing on two rare diseases and backed by leading healthcare-focused investors OrbiMed and <b>Peter Thiel</b>.
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here